Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript
Appointed director

Astex Pharmaceuticals, Inc (ASTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2014 SC 13G/A APAX PARTNERS EUROPE MANAGERS LTD reports a 0% stake in Astex Pharmaceuticals, Inc.
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/11/2013 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Astex Pharmaceuticals, Inc., effective as of October 11, 2013",
"Bylaws of Astex Pharmaceuticals, Inc., effective as of October 11, 2013"
10/11/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/11/2013 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/10/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/09/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/08/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/08/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/07/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/07/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
09/05/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/05/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/05/2013 8-K Quarterly results
08/09/2013 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
08/09/2013 10-Q Quarterly Report for the period ended June 30, 2013
08/01/2013 8-K Quarterly results
Docs: "Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results"
05/10/2013 10-Q Quarterly Report for the period ended March 31, 2013
04/29/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2013 DEF 14A Form DEF 14A - Other definitive proxy statements
04/29/2013 8-K Quarterly results
Docs: "Astex Pharmaceuticals Reports 2013 First Quarter Financial Results"
03/18/2013 10-K Annual Report for the period ended December 31, 2012
01/18/2013 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
11/09/2012 10-Q Quarterly Report for the period ended September 30, 2012
10/30/2012 8-K Quarterly results
Docs: "Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results"
09/28/2012 8-K Other Events, Financial Statements and Exhibits
08/09/2012 10-Q Quarterly Report for the period ended June 30, 2012
07/30/2012 8-K Form 8-K - Current report
06/28/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Dr. Harren Jhoti",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Dr. Harren Jhoti",
"Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Martin Buckland",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Martin Buckland",
"Severance Benefit Plan for Officers effective June 22, 2012"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy